About the Conference

The aging boomer population contributed $8.3 trillion in economic activity to the 2018 US economy, and that number is projected to triple by 2050. The need for advancements in drugs, devices, diagnostics, and digital health for the treatment of age-related conditions is crucial. Longevity, Health & Innovation (LHI) is a new partnering conference focused on conditions related to aging, market challenges, and solutions via early-stage companies and their promising tech and products. LHI brings fundraising startups together with investors in longevity innovation to make deals in order that today’s seniors live longer, healthier lives.  

Who Should Attend

Longevity, Health & Innovation (LHI) is committed to facilitating conversations that spark early-stage deals across drugs, devices, diagnostics, and digital health that save lives and change the world through healthcare innovation. To advance the most successful deals, all major players, including both buyers and sellers, are saved a seat at the table.

Investors

Investors get a front-row seat to emerging early-stage companies, with direct insight into product pipelines, licensing opportunities, financing rounds, technologies, licensing deals, and management details in order to find the best fit for their theme.

Start-Ups

Early-stage CEOs gain access to investors and strategic partners actively seeking opportunities that match their product set and stage of development, from Seed to Series B, through a match-based partnering system, pitch session opportunities, and industry expert panels.

Service Providers

Deal-making is not just a two-way street. The early-stage arena can be challenging to navigate without the help of law firms, broker-dealers, CROs/CMOs, and consulting services to assist in bringing a bright prospect to market.

What to Expect

In order to provide maximum value, Longevity, Health & Innovation goes beyond traditional partnering with a matching system to connect buyers and sellers based on product and development stage fit. In addition to partnering, attendees are invited to participate in featured pitch sessions, expert panels, and industry workshops – each designed with the early-stage player in mind.

Sponsors & Exhibitors

Sponsorship can help your company gain unprecedented visibility into the early-stage life science community, and also leverage our close-knit network of key decision-makers to make promising connections with future clients and strategic partners. To learn more and request a sponsorship brochure, contact us at info@lifesciencenation.com.

Title Sponsor

Gold Sponsors

Silver Sponsors

Bronze Sponsor

Life Science Nation (LSN) was founded to help move science forward and be part of the change that is coming to the life science domain. Capital is the missing ingredient holding back the advancement of life science today. LSN remains dedicated to helping emerging life science companies identify and connect with early-stage investors, and our story has just begun.

Contact Us

Founded in 2003 with a headquarters in San Francisco, Mary Furlong & Associates (MFA) is an event producer and consulting firm for corporations in the healthcare and longevity marketplace, serving private clients, corporations, investors, non-profits and entrepreneurs in learning and sharing about the longevity market through an online store, a market-leading newsletter, and virtual events.

Learn More

LSN Healthtech Partnering Week

Life Science Nation (LSN) Healthtech Partnering Week 2021 launches March 15-19, 2021 with a multi-day partnering event – four digital partnering conferences: Redefining Early Stage Investments (RESI), Access China, 4D Meets AI, and Longevity, Health & Innovation (LHI). LSN has seen tremendous growth in early-stage partnerships throughout life science and healthcare and looks forward to expanding through the week-long partnering event.